UnitedHealth Group Incorporated's Q3 2025 results beat expectations, driving stock growth and optimism. Click for my updated look at UNH stock post earnings.

If UnitedHealth Group’s (NYSE: UNH) stock price implosion was driven by margin, earnings, and capital return concerns, the Q3 results put them to rest. While the business reflects margin impacts, top and bottom-line results are better than expected,

UnitedHealth Group's third quarter revenues grew 12% to $113.2 billion, but headwinds have created challenges for the company, with CEO Stephen Helmsley saying there was a “key sense of urgency” across the company to return to performance standards.

UnitedHealth (NYSE:UNH) shares rose in the premarket on Tuesday after the managed care giant beat Wall Street expectations with its Q3 results and raised its full-year earnings outlook. Shares of the Eden Prairie,

UnitedHealth reported Q3 revenue of $113.2 billion and EPS of $2.92, beating estimates and raising its full-year outlook.

Q3 earnings beat at $2.92/share drives shares up 4.1%. Company raises guidance as recovery continues. See full results.

UnitedHealth (UNH) stock is gaining as Q3 earnings are near, boosted by CEO Hemsley’s return and strong forecasts.

Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including UnitedHealth Group (UNH) shares rising after posting third quarter earnings results and hiking its full-year guidance,